市场调查报告书
商品编码
1438128
2030 年眼科包装市场预测:按产品、类型、剂量、原材料、最终用户和地区进行的全球分析Ophthalmic Packaging Market Forecasts to 2030 - Global Analysis By Product (Plastic Droptainer Bottles, Glass Dropper Bottles, Metal Collapsible Tubes, Plastic Collapsible Tubes and Other Products), Type, Dose, Raw Material, End User and By Geography |
根据Stratistics MRC预测,2023年全球眼科包装市场规模将达115亿美元,预计2030年将达到231亿美元,预测期内复合年增长率为10.4%。
眼科包装在敏感眼科药物的保护和输送中发挥重要作用。这些专用包装经过精确、精心设计,考虑到无菌、准确性和易用性等因素。通常,眼科包装使用符合监管标准的材料,以确保无菌和密封并保持产品的有效性。清晰的标籤有助于正确使用,防篡改功能可增强消费者的信心。包装的人体工学设计优先考虑使用者的便利性,并有利于分配和储存。
根据美国一般人口横断面调查(2018年),约有16.7至5020万美国患有干眼症,占总人口的5%至15%。
与眼睛相关的疾病和病症增加
随着白内障和青光眼等疾病在全球范围内患病率的增加,对确保眼科产品安全、有效和正确剂量的专用包装的需求不断增长。这推动了包装设计的创新,融合了先进的药物输送系统和防篡改措施等功能。对遵守严格监管标准的需求日益增长,以及对消费者友好和方便的包装的重视,进一步推动了眼科包装市场的发展。
保存期限有限
包装解决方案必须确保产品稳定性并防止短期内劣化,从而增加复杂性和成本。製造商面临着满足严格要求以保持敏感配方有效性的挑战。保质期短需要快速生产和分销,从而增加了营运成本。此外,频繁的产品变化会对库存管理造成压力。这种限制不仅限制了包装设计的弹性,而且阻碍了成本效益并影响了报酬率。
提高消费者对眼睛健康的认知
意识的提高促使消费者优先考虑眼睛护理,从而导致对眼科产品的需求激增。因此,包装透过确保产品的安全性、有效性和便利性,在赢得和保留客户方面发挥着至关重要的作用。品牌被迫投资于具有视觉吸引力和资讯丰富的包装,以传达眼部护理产品的好处,建立消费者信任并推动市场成长。
由于竞争激烈,原料的供应情况
满足严格的监管要求需要进行大量的测试、记录并遵守复杂的准则,从而增加了开发和生产成本。这对于中小企业来说尤其是负担,并可能阻碍他们进入市场的能力。需要不断更新以符合不断变化的法规,这进一步加剧了资源的紧张。此外,严格的标准会限制弹性和创新,阻碍市场成长,因为公司优先考虑合规性而不是探索新颖的包装解决方案。
COVID-19 的影响
锁门、旅行限制和消费者优先事项的变化正在减少对非必需品(包括某些眼部护理产品)的需求。此外,医疗保健资源集中在与流行病相关的问题上,转移了人们对常规眼部保健的注意力。这些因素综合在一起,导致眼科包装市场暂时低迷。
塑胶容器领域预计将在预测期内成为最大的领域
塑胶容器重量轻且耐用,为眼药水提供安全的环境,保护眼药水免受污染并保持功效。塑胶容器的采用提高了眼科产品的易用性并延长了保质期。此外,成本效益和易于製造也促进了市场的成长。
预计眼霜细分市场在预测期内复合年增长率最高
预计眼霜细分市场在预测期内将出现最高的复合年增长率。随着这些配方在治疗和化妆品应用中越来越受欢迎,包装要求也在不断变化。对确保产品完整性和用户便利性的创新包装解决方案的需求正在迅速增长。製造商越来越注重易于使用、气密、不透光的包装,以保持眼霜的功效。眼药水市场的蓬勃发展刺激了眼科包装的创新。
由于眼科疾病盛行率上升、眼科产品出口增加、针对眼科领域的研发投资增加以及参数化包装严格的监管政策,北美将成为预测期内最大的市场占有率。例如,2023 年 2 月,West Pharmaceutical Services 宣布扩大与康宁目前的合作关係。此次扩张还包括康宁 Valor管瓶的独家经销权。它还包括推出该公司的旗舰产品 West Ready Pack,其中包括康宁的 Valor RTU管瓶。
预计亚太地区在预测期内的复合年增长率最高。这是因为需要快速可靠的包装解决方案,以满足安全要求、提高患者舒适度、采用防篡改技术并提供优质产品和产品保护。例如,2023年3月,肖特开始在印度生产琥珀色医用玻璃,以满足不断增长的需求。这项措施扩大了印度和亚洲药品包装製造商可用的硼硅酸玻璃的范围。
According to Stratistics MRC, the Global Ophthalmic Packaging Market is accounted for $11.5 billion in 2023 and is expected to reach $23.1 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Ophthalmic packaging plays a crucial role in protecting and delivering sensitive eye medications. These specialized packages are designed with precision and care, considering factors like sterility, accuracy, and ease of use. These are typically sterile and sealed to maintain product efficacy, ophthalmic packaging employs materials that meet regulatory standards. Clear labeling facilitates proper usage instructions, while tamper-evident features enhance consumer confidence. The packaging's ergonomic design prioritizes user convenience, supporting easy dispensing and storage.
According to the USA General Population Cross-sectional Study, 2018, around 16.7 to 50.2 million Americans have a dry eye disease, accounting for 5% to 15% of the total population.
Increase in eye-related disorders and conditions
As the prevalence of ailments like cataracts and glaucoma rises globally, there is an increased demand for specialized packaging that ensures the safety, efficacy, and proper administration of ophthalmic products. This has led to innovations in packaging design, incorporating features like advanced drug delivery systems and tamper-evident measures. The growing need for compliance with stringent regulatory standards and the emphasis on consumer-friendly, convenient packaging further propel the Ophthalmic Packaging market
Limited shelf life
Packaging solutions must ensure product stability and prevent deterioration within a short timeframe, increasing complexity and cost. Manufacturers face challenges in meeting stringent requirements for preserving the efficacy of sensitive formulations. Short shelf life necessitates rapid production and distribution, raising operational costs. Additionally, frequent product turnover places pressure on inventory management. This constraint not only limits the flexibility of packaging design but also hinders cost-effectiveness, impacting profit margins.
Growing awareness among consumers regarding eye health
Increased awareness prompts consumers to prioritize eye care, leading to a surge in demand for ophthalmic products. Consequently, packaging plays a crucial role in attracting and retaining customers by ensuring product safety, efficacy, and convenience. Brands are compelled to invest in visually appealing and informative packaging to communicate the benefits of their eye care products, fostering consumer trust boosting the market growth.
Availability of raw materials with intense competition
Meeting rigorous regulatory requirements demands extensive testing, documentation, and adherence to complex guidelines, escalating development and production costs. Small and medium-sized enterprises may find it particularly burdensome, hindering their entry into the market. The need for continuous updates to comply with evolving regulations further strains resources. Additionally, the stringent standards may limit flexibility and innovation, as companies prioritize meeting compliance over exploring novel packaging solutions hindering the market growth.
Covid-19 Impact
Lockdowns, travel restrictions, and a shift in consumer priorities have caused a decline in demand for non-essential goods, including certain ophthalmic products. Additionally, the focus on healthcare resources for pandemic-related issues has diverted attention from routine eye care. These factors have collectively resulted in a temporary downturn for the Ophthalmic Packaging market
The plastic droptainer bottles segment is expected to be the largest during the forecast period
The plastic droptainer bottles segment is estimated to have a lucrative growth, as these lightweight and durable containers provide a secure environment for ophthalmic solutions, protecting them from contamination and preserving their efficacy. The adoption of plastic droptainer bottles has led to improved user-friendliness and increased shelf life of ophthalmic products. Their cost-effectiveness and ease of manufacturing have also contributed to market growth.
The eye lotions segment is expected to have the highest CAGR during the forecast period
The eye lotions segment is anticipated to witness the highest CAGR growth during the forecast period, as these formulations gain popularity for their therapeutic and cosmetic applications, packaging requirements have evolved. Demand for innovative packaging solutions, ensuring product integrity and user convenience, has surged. Manufacturers are increasingly focusing on creating user-friendly, airtight, and light-protective packaging to preserve the potency of eye lotions. The dynamic growth in the eye lotion segment has consequently stimulated innovation in Ophthalmic Packaging
North America is projected to hold the largest market share during the forecast period owing to the owing to the rising prevalence of ocular disorders, the growing export of ophthalmic products, increasing investment in R&D specific to the ophthalmic field, and stringent regulatory policies in parametrical packaging. For instance, in February 2023, West Pharmaceutical Services announced the expansion of its current collaboration with Corning. This expansion included exclusive rights to distribute Corning Valour glass vials. It also involved launching the company's primary product, West Ready Pack, containing Corning Valour RTU vials.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to owing to the need for speedy and reliable packaging solutions that fulfil a combination of security requirements, enhance patient comfort, comprise tamper-evident technology, and provide high-quality products and product protection. For instance, in March 2023, SCHOTT launched the production of amber medical glass in India to address rising demand. This initiative extended the availability of borosilicate glass variants to pharma packaging producers in India and Asia.
Key players in the market
Some of the key players in the Ophthalmic Packaging Market include SCHOTT AG, West Pharmaceutical Services, Inc., Mitotech, SA, Akorn, Inc., Santen Pharmaceutical Co., Amcor, Bausch & Lomb Incorporated, Bayer AG, Teva Pharmaceutical Industries Ltd., Gerresheimer AG, Novartis AG, ALLERGAN, Johnson & Johnson Vision, AptarGroup, Inc., F. Hoffmann-La Roche Ltd., Aerie Pharmaceuticals, INC and Merck Sharp & Dohme Corp.
In November 2023, Amcor and NOVA Chemicals announce agreement to source mechanically recycled polyethylene. Increasing the use of rPE in flexible packaging applications is an important element of Amcor's commitment to support packaging circularity.
In July 2023, Santen Agrees to License Agreements and Asset Transfer for its Pharmaceutical Products in North America. Under the terms of the agreement, Santen grants Visiox exclusive rights in the U.S. for product manufacturing and commercialization of OMLONTI?. Santen is eligible to receive sales milestone payments, as well as royalties on net U.S. sales of OMLONTI?.
In July 2022, Mitotech S.A, announced entering a partnership agreement with Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced entering a partnership agreement with Essex Bio-Investment for Phase 3 clinical program.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.